ng-nitroarginine methyl ester and 5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one

ng-nitroarginine methyl ester has been researched along with 5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Ho, WY; Huang, PJ; Lee, KH; Liao, JZ; Tseng, TL	1

Other Studies

1 other study(ies) available for ng-nitroarginine methyl ester and 5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one

Article	Year
Oroxylin-A and its phosphonate derivative potentiate eNOS/NO-mediated relaxation and attenuate vasoconstrictor-induced contraction in the mouse aorta. Journal of pharmacological sciences, 2022, Volume: 150, Issue:4 Topics: Animals; Aorta; Endothelium, Vascular; Flavonoids; Mice; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Organophosphonates; Vasoconstrictor Agents; Vasodilation	2022

Article

Year

Oroxylin-A and its phosphonate derivative potentiate eNOS/NO-mediated relaxation and attenuate vasoconstrictor-induced contraction in the mouse aorta.

Journal of pharmacological sciences, 2022, Volume: 150, Issue:4

Topics: Animals; Aorta; Endothelium, Vascular; Flavonoids; Mice; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Organophosphonates; Vasoconstrictor Agents; Vasodilation

2022